Quarterly ResultMay 5, 2026, 07:07 AM
Pediatrix Q1 Net Income +42.6% to $29.57M; Diluted EPS $0.36
AI Summary
Pediatrix Medical Group reported a significant increase in net income and diluted earnings per share for the first quarter of 2026. Net income rose by 42.6% to $29.57 million, with diluted EPS increasing by 50% to $0.36. The company also completed the acquisition of a maternal-fetal medicine practice for $7.9 million and repurchased 1.0 million shares of its common stock for $19.9 million during the quarter.
Key Highlights
- Net income increased by 42.6% to $29.57 million for Q1 2026, up from $20.74 million in Q1 2025.
- Diluted EPS rose by 50% to $0.36 in Q1 2026, compared to $0.24 in Q1 2025.
- Net revenue for Q1 2026 was $476.20 million, a 3.9% increase from $458.36 million in Q1 2025.
- Acquired one maternal-fetal medicine practice for $7.9 million, expanding its national network.
- Repurchased 1.0 million shares of common stock for $19.9 million, with $146.3 million remaining.
- Cash and cash equivalents stood at $205.78 million as of March 31, 2026.
- Total assets were $2.07 billion and total liabilities were $1.19 billion as of March 31, 2026.
Price Impact
More from MD